Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Products>This Product
  Products


caLIMS v2

Product Description

Moxie Informatics builds custom LIMS software for the biotech industry designed to fit any size laboratory at an affordable price. From their work developing LIMS for the National Cancer Institute, Moxie is capable of providing generic solutions from many different laboratory settings.

Moxie Informatics is a health informatics company comprised of experts who are skilled and experienced in the business of Life Science research and Health Care. Their team is intimately familiar with the business of the National Cancer Institute and many of its offices and programs. Moxie’s team resources currently interface with NCI Directors, Program Managers and other government or contractor experts who are working within the CBIIT/caBIG enterprise. Their specific focus is in the areas of program management and providing innovative-value added information technology services to the scientific research community.

Developed by Moxie Informatics, the National Cancer Institute's caLIMS v2 project was launched to create a LIMS that is interoperable within established caBIG standards and guidelines and will track a complete laboratory workflow that uses materials from a specimen management service (e.g. caTissue) to generate experimental results for one of the caBIG data management services (e.g. caArray). The caLIMSv2.c3i0 milestone release is an early release version of the planned caLIMS v2.0 beta release. This caLIMSv2.c3i0 contains much of the functionality related to the administration, customer service, inventory, and reports modules, including: set up of laboratories and users, locations and storage, equipment and software; customer requests, services, and accounts; containers, specimens, reagents, and supplies; and queries, searches, and reports. The goal of this release is to allow the interested community full access to the project results so far for their evaluation, feedback, and possible local customization. Information on the release can be found on the National Cancer Institute's caLIMS v2 Project Wiki at http://www.cancer.gov.

Product caLIMS v2
Company Moxie Informatics
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Moxie Informatics
155 Gibbs St., Suite 506 Rockville, MD 20855 USA

Tel: +1 866-205-3962

Email: info@moxieinforamtics.com



Scientific News
Open Source Seed Initiative – A Welcome Boost to Global Crop Breeding
A team of plant breeders, farmers, non-profit agencies, seed advocates, and policymakers have created the Open Source Seed Initiative.
ASMS 2016: Targeting Mass Spectrometry Tools for the Masses
The expanding application range of MS in life sciences, food, energy, and health sciences research was highlighted at this year's ASMS meeting in San Antonio, Texas.
A New Way Out for Stem Cells
Researchers at North Carolina State University have discovered that therapeutic stem cells exit the bloodstream in a different manner than was previously thought.
One Giant Leap for the Future of Safe Drug Delivery
Sheffield engineers make major breakthrough in developing silk ‘micro-rockets’ that can be used safely in biological environments.
Designing Potential AIDS Vaccine Candidates
Findings represent ‘big accomplishment’ in biomedical engineering and design.
Anticancer Drug Stops Ebola Virus Molecule in its Tracks
A team of scientists from the University of Oxford have successfully mapped the structure of the Ebola virus molecule that drives the attack strategy and leads to fatal infections in humans.
Assessing the Effectiveness of Genome-Editing Technologies
Researchers have developed a cost-effective and rapid method for assessing edits generated by CRISPR-Cas9 and other genome-editing technologies.
Anthrax Proteins Might Help Treat Cancerous Tumors
Studies in mice reveal novel treatment regimen.
New Cancer Drug Target Found in Dual-Function Protein
Findings from a study from TSRI have shown that targeting a protein called GlyRS might help to halt cancer growth.
Key to Chronic Fatigue Syndrome is in Your Gut, Not Head
Researchers report they have identified biological markers of the disease in gut bacteria and inflammatory microbial agents in the blood.
Scroll Up
Scroll Down

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!